市場調查報告書
商品編碼
1105570
全球弱視治療市場規模調查:按治療類型、分銷渠道和地區劃分的預測(2022-2028 年)Global Amblyopia Treatment Market Size study, By Treatment Type, By Distribution Channel, and Regional Forecasts 2022-2028 |
弱視患者人數的增加,對眼罩、眼藥水和眼鏡的需求增加,以及對先進產品技術開發的日益關注,正在推動弱視治療市場的增長。
但是,缺乏對殘疾的認識和缺乏熟練的專業人員正在限制市場的增長。
本報告研究和分析全球弱視治療市場,提供包括市場動態、行業分析、市場分析和競爭信息在內的系統信息。
Global Amblyopia Treatment Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Amblyopia is a condition in which an individual's eyesight decreases because of abnormal visual development. This condition majorly occurs during childhood and results in the interruption of normal cortical visual pathway development. Factors such as the increasing number of amblyopia cases, surging demand for eye patches, spectacle lenses, eye drops & ointments, and glasses, coupled with the rising focus on technological development for advanced products are driving the global market growth. For instance, according to Statista, in 2022, the spectacle lenses segment generated a revenue of USD 50.33 billion in 2022 and the market is projected to reach 74.23 billion by 2025 with a growth rate of 8.08%. Thereby, the growing adoption of spectacle lenses is showing a positive influence on the growth of the Amblyopia Treatment Market across the globe. However, a lack of awareness regarding the disorder and a dearth of skilled professionals impedes the growth of the market over the forecast period of 2022-2028. Also, the increasing number of initiatives by the key market players and rising healthcare spending are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Amblyopia Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing integration of advanced technology to offer better treatment and presence of highly skilled professionals. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the rising presence of target population, as well as increasing healthcare expenditure, would create lucrative growth prospects for the Amblyopia Treatment Market across the Asia-Pacific region.
Major market players included in this report are:
Vivid Vision
3M
Lancastle International Ltd
Johnson and Johnson
Trayner
Good-Lite
HOYA Vision Care Company
Ortopad USA
NovaSight
Revital Vision
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type:
Eye Patches
Spectacle Lenses
Eye Drops & Ointments
Surgery
Others
By Distribution Channel:
Pharmacies
Drug Stores
Hypermarkets and Supermarkets
E-Commerce
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Amblyopia Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures